Perspectum Diagnostics released details regarding the latest version of its LiverMultiScan magnetic resonance imaging technology which identified nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, according to a press release. The latest version of LiverMultiScan, known as LiverMultiScan IDEAL, will feature machine learning-based, automatic segmentation of cT1 and proton density fat fraction parametic maps of the liver parenchyma and be accessible on more field strengths across major scanner manufacturers.
To read the full story, visit: Healio
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off